Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study

In this study, in estrogen receptor positive (ER+) early stage breast cancer patients who were considered candidates for 70-gene signature (70-GS, “MammaPrint”) use, we compared molecular subtyping (MS) based on the previously validated 80-gene signature (80-GS, “BluePrint”) versus surrogate patholo...

Descripción completa

Detalles Bibliográficos
Autores principales: van Steenhoven, Julia E.C., Kuijer, Anne, van Diest, Paul J., van Gorp, Joost M., Straver, Marieke, Elias, Sjoerd G., Wesseling, Jelle, Rutgers, Emiel, Timmer-Bonte, Johanna N.H., Nieboer, Peter, Smilde, Tineke J., Imholz, Alex, Blanken, Charlotte F.J.M., Siesling, Sabine, van Dalen, Thijs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977201/
https://www.ncbi.nlm.nih.gov/pubmed/29772837
http://dx.doi.org/10.3390/genes9050261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977201/
https://www.ncbi.nlm.nih.gov/pubmed/29772837
http://dx.doi.org/10.3390/genes9050261

Ejemplares similares